<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01545414</url>
  </required_header>
  <id_info>
    <org_study_id>ICBT Parkinson</org_study_id>
    <nct_id>NCT01545414</nct_id>
  </id_info>
  <brief_title>Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease</brief_title>
  <official_title>Internet-based CBT for Depression and Anxiety in Parkinson's Disease: a Pilot Study and Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral
      Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety
      symptoms. All treatment in this project is given as an adjunct to Standard Medical Treatment
      (SMT). ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to
      SMT alone. It is hypothesized that both active treatments will be superior to SMT, and that
      ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change (from baseline) in HADS</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in MADRS-S</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>Montgomery and Asberg Depressions Rating Scale - Self report, to measure level of depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in ISI</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>Insomnia Severity Index - self-report, to measure insomnia symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in PDQ-8</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>The Parkinson's Disease Questionnaire-8, to measure various health aspects specific for PD patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in EQ-5D</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>EQ-5D, to measure general health and quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in SDS</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>Sheehan Disability Scale, to measure everyday level of functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in NMSQuest</measure>
    <time_frame>12 weeks (Post), 3 and 6 months (FU)</time_frame>
    <description>Non-Motor Symptoms Questionnaire, to measure the non-motor symptoms in PD</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>ICBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet-based Cognitive Behavioral Therapy with a focus on behavioral activation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICONTROL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Internet-based treatment with a focus on relaxation training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMT</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Medical Treatment while being on the waitlist for randomization to any of the active treatments</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ICBT</intervention_name>
    <description>12 weeks of Internet-based Cognitive Behavioral Therapy with a focus on behavioral activation</description>
    <arm_group_label>ICBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ICONTROL</intervention_name>
    <description>12 weeks of Internet-based treatment with a focus on relaxation training</description>
    <arm_group_label>ICONTROL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Parkinson's Disease

          -  At least mild to moderate depression or anxiety defined as HADS-A or HADS-D &gt; 7

        Exclusion Criteria:

          -  Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview

          -  Somatic or psychiatric problems that are directly contraindicated or seriously hamper
             the implementation of the treatment (eg, psychotic disorders or bipolar disorder)

          -  Difficulties that hamper the use of a computer

          -  The patient states difficulties in finding enough time for treatment

          -  Too low cognitive functioning defined as MoCA &lt; 24

          -  Too severe depression, defined as MADRS-S over 30

          -  Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or
             according to the structured assessment interview
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viktor Kaldo, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydv√§st, SLSO</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://www.internetpsykiatri.se</url>
    <description>The public page of the Internet-CBT treatment platform</description>
  </link>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2012</study_first_submitted>
  <study_first_submitted_qc>March 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2012</study_first_posted>
  <last_update_submitted>February 12, 2015</last_update_submitted>
  <last_update_submitted_qc>February 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Viktor Kaldo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Self-help treatment</keyword>
  <keyword>Internet treatment</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Internet-based Cognitive Behavioral Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

